Pharmacy SIG - Online Advocacy and Policy Toolkit

ASBMT Pharmacy SIG Advocacy & Policy “Toolkit”

 

Hematology/Oncology Pharmacy Association (HOPA)

Issue briefs

  • Biosimilars ‒ Ensure that biosimilar drugs reach the market but do not impact patient safety.
  • Counterfeit Drug Prevention – Describes the issue of counterfeit drugs and recommendations for legislative changes that aid in the prevention of counterfeit drug availability in the U.S. market.
  • Drug shortages – Address the growing oncology drug shortages which prohibit patients from accessing or receiving the agents necessary for the treatment of cancer and cancer-related symptoms.
  • H.R. 592/S. 314 Fact Sheet – Support the hematology/oncology pharmacist as an essential component of patient care and recognize them as providers under Medicare Part B.
  • Oral chemotherapy – Improve access to oral chemotherapy for all patients; develop guidelines to promote safety in ordering, dispensing, and administering oral chemotherapy
  • Pain Management ‒ Ensure the responsible use of and access to pain medications for cancer patients
  • Role of the hematology/oncology pharmacist – Promote and improve patient safety by realizing the value and role that hematology/oncology pharmacists play in healthcare delivery.